These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24601956)

  • 1. Donors deferred for self-reported Chagas disease history: does it reduce risk?
    Steele WR; Hewitt EH; Kaldun AM; Krysztof DE; Dodd RY; Stramer SL
    Transfusion; 2014 Aug; 54(8):2092-7. PubMed ID: 24601956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chagas disease and blood transfusion: an emerging issue in non-endemic countries].
    Assal A; Corbi C
    Transfus Clin Biol; 2011 Apr; 18(2):286-91. PubMed ID: 21440479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective testing for Trypanosoma cruzi: the first year after implementation at Canadian Blood Services.
    O'Brien SF; Scalia V; Goldman M; Fan W; Yi QL; Dines IR; Huang M; Ndao M; Fearon MA
    Transfusion; 2013 Aug; 53(8):1706-13. PubMed ID: 23145895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of a travel question to identify donors with risk of Trypanosoma cruzi: operational validity and field testing.
    O'Brien SF; Chiavetta JA; Fan W; Xi G; Yi QL; Goldman M; Scalia V; Fearon MA
    Transfusion; 2008 Apr; 48(4):755-61. PubMed ID: 18194375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testing blood donors for Chagas disease in the Paris area, France: first results after 18 months of screening.
    El Ghouzzi MH; Boiret E; Wind F; Brochard C; Fittere S; Paris L; Mazier D; Sansonetti N; Bierling P
    Transfusion; 2010 Mar; 50(3):575-83. PubMed ID: 19906038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiologic and laboratory findings from 3 years of testing United States blood donors for Trypanosoma cruzi.
    Custer B; Agapova M; Bruhn R; Cusick R; Kamel H; Tomasulo P; Biswas H; Tobler L; Lee TH; Caglioti S; Busch M
    Transfusion; 2012 Sep; 52(9):1901-11. PubMed ID: 22339233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfusion-associated Chagas disease (American trypanosomiasis) in Mexico: implications for transfusion medicine in the United States.
    Kirchhoff LV; Paredes P; Lomelí-Guerrero A; Paredes-Espinoza M; Ron-Guerrero CS; Delgado-Mejía M; Peña-Muñoz JG
    Transfusion; 2006 Feb; 46(2):298-304. PubMed ID: 16441610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission.
    Leiby DA; Herron RM; Read EJ; Lenes BA; Stumpf RJ
    Transfusion; 2002 May; 42(5):549-55. PubMed ID: 12084162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chagas disease and transfusion medicine: a perspective from non-endemic countries.
    Angheben A; Boix L; Buonfrate D; Gobbi F; Bisoffi Z; Pupella S; Gandini G; Aprili G
    Blood Transfus; 2015 Oct; 13(4):540-50. PubMed ID: 26513769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European strategies against the parasite transfusion risk.
    Reesink HW
    Transfus Clin Biol; 2005 Feb; 12(1):1-4. PubMed ID: 15814284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The early implementation of Trypanosoma cruzi antibody screening of donors and donations within England: preempting a problem.
    Kitchen AD; Hewitt PE; Chiodini PL
    Transfusion; 2012 Sep; 52(9):1931-9. PubMed ID: 22414025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trypanosoma cruzi in a low- to moderate-risk blood donor population: seroprevalence and possible congenital transmission.
    Leiby DA; Fucci MH; Stumpf RJ
    Transfusion; 1999 Mar; 39(3):310-5. PubMed ID: 10204596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chagas disease: a proposal for testing policy for solid-organ transplant in the United States.
    Wallace JA; Miller L; Beavis A; Baptista CA
    Prog Transplant; 2013 Sep; 23(3):272-7. PubMed ID: 23996948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood donor screening for chagas disease--United States, 2006-2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Feb; 56(7):141-3. PubMed ID: 17318113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analyzing actual risk in malaria-deferred donors through selective serologic testing.
    Nguyen ML; Goff T; Gibble J; Steele WR; Leiby DA
    Transfusion; 2013 Aug; 53(8):1736-43. PubMed ID: 23216377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of Trypanosoma cruzi infection in at-risk blood donors in Catalonia (Spain).
    Piron M; Vergés M; Muñoz J; Casamitjana N; Sanz S; Maymó RM; Hernández JM; Puig L; Portús M; Gascón J; Sauleda S
    Transfusion; 2008 Sep; 48(9):1862-8. PubMed ID: 18522707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of lookback for Chagas disease since the inception of donor screening at New York Blood Center.
    Kessler DA; Shi PA; Avecilla ST; Shaz BH
    Transfusion; 2013 May; 53(5):1083-7. PubMed ID: 22897737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The United States Trypanosoma cruzi Infection Study: evidence for vector-borne transmission of the parasite that causes Chagas disease among United States blood donors.
    Cantey PT; Stramer SL; Townsend RL; Kamel H; Ofafa K; Todd CW; Currier M; Hand S; Varnado W; Dotson E; Hall C; Jett PL; Montgomery SP
    Transfusion; 2012 Sep; 52(9):1922-30. PubMed ID: 22404755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a questionnaire to identify potential blood donors at risk for infection with Trypanosoma cruzi.
    Appleman MD; Shulman IA; Saxena S; Kirchhoff LV
    Transfusion; 1993 Jan; 33(1):61-4. PubMed ID: 8424268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pragmatic data and observations related to the epidemiology of Chagas disease].
    Schenone H; Rojas A
    Bol Chil Parasitol; 1989; 44(3-4):66-86. PubMed ID: 2518649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.